thought leadership

COVID-19: 'Pandemic-ready' set-up placing Emergent apart in CDMO Space

In a recent article with BioProcess International, Syed T. Husain, senior vice president & CDMO business unit head at Emergent BioSolutions, discusses the critical role Emergent has in supporting the development & manufacturing of COVID-19 vaccine candidates. 

Read the full article here.

Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing

  • Emergent and HHS expand 2012 CIADM public-private partnership with task order valued at approximately $628 million for rapid...
READ MORE

Vaxart + Emergent: In the news

Original news coverage of Vaxart's agreement with Emergent BioSolutions to manufacture and develop an experimental oral vaccine...

READ MORE

Emergent Announces Additions to Leadership Team

Emergent is pleased to announce the addition of two senior leaders to its  CDMO and Quality & Compliance organizations.

READ MORE